Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis

Abstract Background The objective of this study was to examine the degree to which conventional cardiovascular (CV) risk factor changes induced by once-weekly exenatide (EQW) might explain the placebo-controlled differences in CV outcomes observed in the Exenatide Study of Cardiovascular Event Lower...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ruth L. Coleman, Amanda I. Adler, Robert J. Mentz, Marat Fudim, Naveed Sattar, Rury R. Holman
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2025-08-01
Edice:	Cardiovascular Diabetology
Témata:	Glucagon-like peptide-1 receptor agonists Once-weekly exenatide Cardiovascular risk factors Cardiovascular outcomes Model simulation Mediation analyses
On-line přístup:	https://doi.org/10.1186/s12933-025-02866-7
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!